Zevia Pbc Form 4 insider transactions

NYSE
White Pine LLC, a 10% owner and related to a director of Zevia PBC, sold shares of Class A Common Stock on September 30, 2024, and October 1, 2024.
NYSE
White Pine LLC, a 10% owner of Zevia PBC, continues to reduce its holdings, selling shares on September 26th and 27th, 2024.
NYSE
Director Julie Garcia Ruehl increased her holdings in Zevia PBC (ZVIA) through recent stock purchases.
NYSE
Director Alexandre Ruberti purchased 10,000 shares of Zevia PBC's Class A Common Stock at a price of $0.9842 per share on September 3, 2024.
NYSE
Andrew Ruben, a director at Zevia PBC, amended a previous Form 4 filing to correct the description of a stock transaction, clarifying that it was a purchase rather than a sale.
NYSE
Director David J. Lee reports purchasing 13,704.547 shares of Zevia PBC Class A Common Stock at a weighted average price of $1.0945 on August 26, 2024.
NYSE
Director Andrew Ruben reported purchasing 9,560 shares of Zevia PBC Class A Common Stock and disclosed holdings including restricted stock units (RSUs).
NYSE
Director Alexandre Ruberti reports the acquisition of 84,091 restricted stock units (RSUs) in Zevia PBC, vesting on August 20, 2024, or the date of the company's 2024 annual meeting.
NYSE
Director Padraic L. Spence received 118,455 restricted stock units (RSUs) of Zevia PBC Class A Common Stock on June 12, 2024.
NYSE
Director Rosemary L. Ripley reports the grant of restricted stock units (RSUs) and her beneficial ownership of Zevia PBC stock through various entities.
NYSE
Director David J. Lee reports receiving 118,455 restricted stock units (RSUs) of Zevia PBC Class A Common Stock.
NYSE
Director Julie Garcia Ruehl reports the acquisition of 118,455 shares of Zevia PBC Class A Common Stock in the form of restricted stock units (RSUs).
NYSE
Director Jacqueline Hayes received 118,455 restricted stock units (RSUs) in Zevia PBC, according to a recent SEC filing.
NYSE
Director Andrew Ruben reports the acquisition of 118,455 restricted stock units (RSUs) of Zevia PBC Class A Common Stock.
NYSE
Zevia PBC's CEO, Amy Taylor, recently purchased 55,000 shares of Class A Common Stock at an average price of $0.891, while also agreeing to disgorge profits from the transaction.
NYSE
Director Rosemary L. Ripley reports the exchange of Class B Units for Class A Common Stock in Zevia PBC on December 1, 2023.
NYSE
Director Padraic L. Spence sold 36,300 shares of Zevia PBC Class A Common Stock to cover tax liabilities related to the settlement of restricted stock units.
NYSE
Zevia PBC's CEO, Amy Taylor, sold 30,703 shares of Class A Common Stock to cover tax liabilities related to the settlement of restricted stock units (RSUs).
NYSE
Lorna R. Simms, SVP, GC & Corporate Secretary of Zevia PBC, sold shares to cover tax liabilities related to the settlement of restricted stock units.
NYSE
Lorna R. Simms, SVP, GC & Corporate Secretary of Zevia PBC, sold 5,120 shares of Class A Common Stock to cover tax liabilities related to the settlement of restricted stock units (RSUs).
NYSE
Greig P. DeBow, Jr., Chief Commercial Officer of Zevia PBC, sold shares of Class A Common Stock to cover tax liabilities related to the settlement of restricted stock units.
NYSE
Mikhail Hany, Chief Accounting Officer of Zevia PBC, sold 3,723 shares of Class A Common Stock to cover tax liabilities related to the settlement of restricted stock units.
NYSE
Padraic L. Spence, a director of Zevia PBC, sold 26,199 shares of Class A Common Stock on March 13, 2024, to cover tax liabilities related to the settlement of restricted stock units.
NYSE
Greig P. DeBow, Jr., Chief Commercial Officer of Zevia PBC, received 200,000 restricted stock units (RSUs) on March 11, 2024, according to a Form 4 filing.
NYSE
Zevia PBC's CEO, Amy Taylor, was granted 600,000 restricted stock units (RSUs) on March 11, 2024, according to a Form 4 filing.
NYSE
Chief Financial Officer Girish Satya reports the acquisition of restricted stock units and stock options in Zevia PBC.
NYSE
Lorna R. Simms, SVP, GC & Corporate Secretary of Zevia PBC, reports the grant of restricted stock units and a correction to previously reported holdings.